In addition to POMC, other markers in the ARC that potentially represent targets for GLP-1RAs are currently being studied
However, many BCBS plans classify Zepbound as an "anti-obesity agent" and exclude it for any indication if the plan excludes weight loss drugs
The longer answer requires understanding why GLP-1 receptor agonists raise pharmacokinetic questions for any concomitant oral drug, and why PPIs specifically are low-risk in this pairing
However, pricing structures that make these medications accessible primarily to affluent consumers create a troubling two-tier system where metabolic health interventions stratify along economic lines
There are no needles involved so it feels just like adding another supplement to your routine, which is the appeal for people who want something low-effort and familiar
By supporting fatty acid oxidation, it helps maintain heart muscle efficiency and skeletal muscle performance